Singapore Medical Group Ltd
SGX:5OT
Relative Value
There is not enough data to reliably calculate the relative value of 5OT.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
5OT Competitors Multiples
Singapore Medical Group Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SG |
|
Singapore Medical Group Ltd
SGX:5OT
|
192.2m SGD | 1.8 | 13.1 | 6.7 | 10.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
90.2B USD | 0.2 | 51.3 | 13.4 | 13.4 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.4B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
69.1B USD | 0.3 | 11.7 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
25.1B EUR | 1.1 | 19.4 | 9.3 | 13.8 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.5B EUR | 1.1 | 23 | 8.9 | 16.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.6 | 24.8 | 11.9 | 17.3 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.5B USD | 2 | 21.8 | 11.8 | 15.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.5B EUR | 0.5 | 10.8 | 5.2 | 9.7 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 11.6 | -27.3 | -29.9 | -27.2 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 0.8 | 13.9 | 7.2 | 9.7 |